These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 667864)

  • 1. Systolic time intervals in monitoring adriamycin-induced cardiotoxicity.
    Balcerzak SP; Christakis J; Lewis RP; Olson HM; Malspeis L
    Cancer Treat Rep; 1978 Jun; 62(6):893-9. PubMed ID: 667864
    [No Abstract]   [Full Text] [Related]  

  • 2. Adriamycin-induced cardiotoxicity (cardiomyopathy and congestive heart failure) in rats.
    Mettler FP; Young DM; Ward JM
    Cancer Res; 1977 Aug; 37(8 Pt 1):2705-13. PubMed ID: 872096
    [No Abstract]   [Full Text] [Related]  

  • 3. Noninvasive profile in the prospective monitoring of adriamycin cardiomyopathy.
    Fulkerson PK; Talley R; Kleinman D; Weaver SK; Leier CV; Balcerzak SP; Lewis RP
    Cancer Treat Rep; 1978 Jun; 62(6):881-6. PubMed ID: 667862
    [No Abstract]   [Full Text] [Related]  

  • 4. Systolic time intervals in monitoring for anthracycline cardiomyopathy in pediatric patients.
    Hutchinson RJ; Bailey C; Wood D; Donaldson MH
    Cancer Treat Rep; 1978 Jun; 62(6):907-10. PubMed ID: 667866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclinical adriamycin cardiotoxicity: detection by timing the arterial sounds.
    Greco FA
    Cancer Treat Rep; 1978 Jun; 62(6):901-5. PubMed ID: 667865
    [No Abstract]   [Full Text] [Related]  

  • 6. Systolic time intervals: an effective measure of cardiac function in anthracycline-induced cardiomyopathy of rabbits.
    Long HJ
    Cancer Treat Rep; 1978 Jun; 62(6):911-4. PubMed ID: 667867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Possible role of adriamycinol in the cardiotoxicity induced by adriamycin in the rat].
    Danesi R; Del Tacca M; Ducci M; Bernardini C; Romanini A
    G Ital Chemioter; 1985; 32(1):31-3. PubMed ID: 3830790
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiac toxicity of adriamycin-DNA complex and rubidazone: evaluation by electrocardiogram and endomyocardial biopsy.
    Benjamin RS; Mason JW; Billingham ME
    Cancer Treat Rep; 1978 Jun; 62(6):935-9. PubMed ID: 667871
    [No Abstract]   [Full Text] [Related]  

  • 9. Adriamycin cardiotoxicity amelioration by alpha-tocopherol.
    Krivit W
    Am J Pediatr Hematol Oncol; 1979; 1(2):151-3. PubMed ID: 543510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of noninvasive cardiac parameters in the detection and evaluation of adriamycin cardiotoxicity.
    Shuman RD; Ettinger DS; Abeloff MD; Livengood SV; Fortuin NJ
    Johns Hopkins Med J; 1981 Aug; 149(2):57-63. PubMed ID: 7253365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinicopathologic analysis of adriamycin cardiotoxicity.
    Lefrak EA; Pitha J; Rosenheim S; Gottlieb JA
    Cancer; 1973 Aug; 32(2):302-14. PubMed ID: 4353012
    [No Abstract]   [Full Text] [Related]  

  • 12. [Adriamycin: cardiotoxicity].
    Gamna G; Lovisetto P; Pochnettino G; Biarese V
    Boll Soc Ital Cardiol; 1974; 19(7):633-70. PubMed ID: 4464961
    [No Abstract]   [Full Text] [Related]  

  • 13. Electrocardiographic and biochemical evidence for the cardioprotective effect of vitamin E in doxorubicin-induced acute cardiotoxicity in rats.
    Puri A; Maulik SK; Ray R; Bhatnagar V
    Eur J Pediatr Surg; 2005 Dec; 15(6):387-91. PubMed ID: 16418954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiotoxicity of anthracyclines in children. Contribution of anthracyclines in pediatric oncology].
    Biron P; Philip T; Bouffet E; Favrot MC; Pinkerton R; Brunat-Mentigny M
    Pathol Biol (Paris); 1987 Jan; 35(1):97-101. PubMed ID: 3550619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive monitoring of adriamycin cardiotoxicity by "Sphygmo-Recording" of the pulse wave delay (QKd interval).
    Greco FA; Brereton HD; Rodbard D
    Cancer Treat Rep; 1976 Sep; 60(9):1239-45. PubMed ID: 797446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiotoxicity of adriamycin].
    Mordeglia F; Mirassou C
    Medicina (B Aires); 1979; 39(3):423-5. PubMed ID: 514062
    [No Abstract]   [Full Text] [Related]  

  • 17. [Adriamycin cardiotoxicity].
    Recalcatri F; Villa A; Belli C
    G Ital Cardiol; 1982; 12(8):612-6. PubMed ID: 7169160
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cardiotoxicity of anthracycline cytostatic agents--a proposal for routine monitoring and supportive therapy].
    Svojgrová M; Slechtová J; Hůla J
    Vnitr Lek; 1991 Feb; 37(2):151-9. PubMed ID: 2021075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic involvement in adriamycin cardiotoxicity.
    Seraydarian MW; Artaza L; Yang JJ
    Adv Myocardiol; 1980; 2():213-23. PubMed ID: 7423039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of the cardiac toxicity of 4'-deoxy-doxorubicin.
    Villani F; Galimberti M; Comazzi R; Crippa F; Bonfante V; Ferrari L; Pacciarini MA
    Int J Clin Pharmacol Ther Toxicol; 1988 Apr; 26(4):185-9. PubMed ID: 3403095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.